Allergic conjunctivitis laboratory findings: Difference between revisions
Jump to navigation
Jump to search
| Line 13: | Line 13: | ||
*The patient cannot discontinue [[antihistaminic]] [[medications]] | *The patient cannot discontinue [[antihistaminic]] [[medications]] | ||
===[[Conjunctival]] [[allergen]] challenge=== | ===[[Conjunctival]] [[allergen]] challenge=== | ||
* It involves instillation of an [[allergen]] on the [[conjunctiva]] of the affected [[eye]] and a control solution in the other [39]. | |||
* More common in [[research]] settings to test [[novel]] [[treatments]] or to compare existing [[therapies]] | |||
* Clinically helpful to identify local [[allergies]] in suspect patients but with negative or discordant [[skin]] prick testing and [[serum]] specific [[IgE]] [29]. *Useful to assess the relationship between [[symptoms]] and [[exposure]] in [[polysensitized]] [[patients]] and the response to initiated therapy.[29, 39]. | |||
==References== | ==References== | ||
Revision as of 04:07, 30 August 2022
|
Allergic conjunctivitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Allergic conjunctivitis laboratory findings On the Web |
|
American Roentgen Ray Society Images of Allergic conjunctivitis laboratory findings |
|
Risk calculators and risk factors for Allergic conjunctivitis laboratory findings |
Overview
Allergic conjunctivitis is usually a clinical diagnosis. Laboratory tests are primarily supportive. They may help in differentiating intrinsic and extrinsic forms of the condition and thus, guide the treatment.
Laboratory findings
Skin prick test
- Intradermal injections of individual allergens are administered to detect sensitivity[1].
- It is a highly sensitive test[2].
- The result is considered positive when the resulting wheal is at least 3 mm larger than the negative control. Systemic reactions are rare[3].
IgE estimation
In-vitro tests to detect IgE antibodies to specific allergens are widely used[4] if skin testing is indicated but not advised such as[5]:
- The patient cannot discontinue antihistaminic medications
Conjunctival allergen challenge
- It involves instillation of an allergen on the conjunctiva of the affected eye and a control solution in the other [39].
- More common in research settings to test novel treatments or to compare existing therapies
- Clinically helpful to identify local allergies in suspect patients but with negative or discordant skin prick testing and serum specific IgE [29]. *Useful to assess the relationship between symptoms and exposure in polysensitized patients and the response to initiated therapy.[29, 39].
References
- ↑ La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S; et al. (2013). "Allergic conjunctivitis: a comprehensive review of the literature". Ital J Pediatr. 39: 18. doi:10.1186/1824-7288-39-18. PMC 3640929. PMID 23497516.
- ↑ Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R; et al. (2008). "Allergy diagnostic testing: an updated practice parameter". Ann Allergy Asthma Immunol. 100 (3 Suppl 3): S1–148. doi:10.1016/s1081-1206(10)60305-5. PMID 18431959.
- ↑ Wilson AM, Orr LC, Sims EJ, Lipworth BJ (2001). "Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis". Clin Exp Allergy. 31 (1): 61–8. PMID 11167952.
- ↑ Arasi S, Corsello G, Villani A, Pajno GB (2018). "The future outlook on allergen immunotherapy in children: 2018 and beyond". Ital J Pediatr. 44 (1): 80. doi:10.1186/s13052-018-0519-4. PMC 6042356. PMID 29996875.
- ↑ Dupuis P, Prokopich CL, Hynes A, Kim H (2020). "A contemporary look at allergic conjunctivitis". Allergy Asthma Clin Immunol. 16: 5. doi:10.1186/s13223-020-0403-9. PMC 6975089 Check
|pmc=value (help). PMID 31993069.